LENSAR (LNSR) Revenue & Revenue Breakdown
LENSAR Revenue Highlights
Latest Revenue (Y)
$58.44M
Latest Revenue (Q)
$14.32M
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
LENSAR Revenue by Period
LENSAR Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $58.44M | 9.24% |
| 2024-12-31 | $53.49M | 26.87% |
| 2023-12-31 | $42.16M | 19.25% |
| 2022-12-31 | $35.36M | 2.61% |
| 2021-12-31 | $34.46M | 30.62% |
| 2020-12-31 | $26.38M | -13.58% |
| 2019-12-31 | $30.53M | 25.18% |
| 2018-12-31 | $24.39M | - |
LENSAR generated $58.44M in revenue during NA 2025, up 9.24% compared to the previous quarter, and up 221.50% compared to the same period a year ago.
LENSAR Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $14.32M | 2.73% |
| 2025-06-30 | $13.94M | -1.58% |
| 2025-03-31 | $14.16M | -15.37% |
| 2024-12-31 | $16.73M | 23.58% |
| 2024-09-30 | $13.54M | 7.15% |
| 2024-06-30 | $12.64M | 19.34% |
| 2024-03-31 | $10.59M | -12.53% |
| 2023-12-31 | $12.11M | 23.58% |
| 2023-09-30 | $9.79M | -18.46% |
| 2023-06-30 | $12.01M | 45.56% |
| 2023-03-31 | $8.25M | -19.35% |
| 2022-12-31 | $10.23M | 32.06% |
| 2022-09-30 | $7.75M | -3.61% |
| 2022-06-30 | $8.04M | -13.94% |
| 2022-03-31 | $9.34M | -16.77% |
| 2021-12-31 | $11.22M | 35.66% |
| 2021-09-30 | $8.27M | 4.42% |
| 2021-06-30 | $7.92M | 12.48% |
| 2021-03-31 | $7.04M | -14.98% |
| 2020-12-31 | $8.28M | 15.94% |
| 2020-09-30 | $7.14M | 41.57% |
| 2020-06-30 | $5.05M | -14.54% |
| 2020-03-31 | $5.91M | -30.19% |
| 2019-12-31 | $8.46M | 4.86% |
| 2019-09-30 | $8.07M | 15.26% |
| 2019-06-30 | $7.00M | - |
| 2019-03-31 | $7.00M | - |
LENSAR generated $14.32M in revenue during Q3 2025, up 2.73% compared to the previous quarter, and up 113.30% compared to the same period a year ago.
LENSAR Revenue Breakdown
LENSAR Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Service | $5.73M | $4.90M | $4.07M | $3.48M | $3.25M |
| Product | $45.93M | $41.06M | $31.64M | $25.96M | $26.25M |
LENSAR's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (88.91%), and Service (11.09%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $1.60M | $1.39M | $1.38M | $1.36M | $2.45M | $1.24M | $1.21M | $1.05M | $1.11M | $944.00K | $965.00K | $832.00K | $790.00K | $890.00K | $972.00K | $844.00K | $903.00K | $726.00K | $774.00K | $731.00K |
| Product | $12.73M | $11.37M | $10.91M | $10.92M | $23.05M | $10.58M | $7.43M | $9.45M | $7.16M | $9.38M | $5.66M | $7.77M | $5.49M | $5.73M | $6.97M | $8.95M | $6.08M | $6.06M | $5.16M | $6.47M |
LENSAR's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (88.82%), and Service (11.18%).
LENSAR Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Other Geographical Region | $238.00K | $563.00K | $776.00K | $502.00K | $449.00K |
| UNITED STATES | $34.31M | $28.91M | $25.26M | $18.78M | $15.00M |
| Asia Excluding South Korea | $8.02M | $5.49M | $3.84M | $3.58M | $3.85M |
| Europe | $8.43M | $10.16M | $5.58M | $4.41M | $5.80M |
| KOREA, REPUBLIC OF | $658.00K | $848.00K | $257.00K | $2.18M | $4.38M |
LENSAR's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (66.43%), Europe (16.31%), Asia Excluding South Korea (15.53%), KOREA, REPUBLIC OF (1.27%), and Other Geographical Region (0.46%).
Quarterly Revenue by Country
| Country | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe | $1.46M | $2.31M | $2.41M | $2.25M | $5.20M | $3.54M | $1.42M | $1.13M | $934.00K | $1.98M | $1.54M | $1.03M | $805.00K | $956.00K | $1.62M | $3.09M | $908.00K | $921.00K | $889.00K | $1.29M |
| UNITED STATES | $11.19M | $8.67M | $7.75M | $6.70M | $16.81M | $6.09M | $6.01M | $8.15M | $5.74M | $7.11M | $4.26M | $6.34M | $4.37M | $4.10M | $3.97M | $4.10M | $3.94M | $3.44M | $4.04M | - |
| Other Geographical Region | $54.00K | $41.00K | $76.00K | $67.00K | $446.00K | $63.00K | $54.00K | $102.00K | $481.00K | $89.00K | $104.00K | $129.00K | $98.00K | $137.00K | $138.00K | $173.00K | $115.00K | $96.00K | $65.00K | $95.00K |
| Asia Excluding South Korea | $1.52M | $1.55M | $1.87M | $3.08M | $2.63M | $1.98M | $884.00K | $896.00K | $1.10M | $1.13M | $708.00K | $1.09M | $932.00K | $771.00K | $780.00K | $1.40M | $1.28M | $633.00K | $542.00K | $746.00K |
| KOREA, REPUBLIC OF | $106.00K | $183.00K | $181.00K | $188.00K | $425.00K | $145.00K | $278.00K | $223.00K | $9.00K | $16.00K | $9.00K | $10.00K | $74.00K | $662.00K | $1.43M | $1.03M | $1.19M | $998.00K | $1.03M | - |
| K R | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.17M | - | - | - |
| U S | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.52M | - | - | - |
LENSAR's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (78.09%), Asia Excluding South Korea (10.63%), Europe (10.16%), KOREA, REPUBLIC OF (0.74%), and Other Geographical Region (0.38%).
LENSAR Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ARAY | Accuray | $458.50M | $102.24M |
| ANIK | Anika Therapeutics | $112.82M | $27.82M |
| OWLT | Owlet | $105.70M | $26.06M |
| LNSR | LENSAR | $58.44M | $14.32M |
| TLSI | TriSalus Life Sciences | $45.15M | $11.21M |
| RPID | Rapid Micro Biosystems | $33.59M | $7.84M |
| MXCT | MaxCyte | $33.03M | $6.83M |
| PROF | Profound Medical | $16.10M | - |
| AVR | Anteris Technologies Global | $1.91M | $618.00K |
| CRBP | Corbus Pharmaceuticals | - | - |
| CRDF | Cardiff Oncology | - | $121.00K |